Live-attenuated dengue vaccine promising in phase 1

被引：0
|
作者：
Riedmann, Eva M.
机构：
来源：
HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2013年 / 9卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：723 / 723
页数：1
相关论文
共 50 条
  • [41] Development of Attenuated and Immunogenic Live-attenuated Respiratory Syncytial Virus Vaccine Candidates
    Hornung, Sandra L.
    Tran, Kim C.
    Teng, Michael N.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB120 - AB120
  • [42] Using recombinant DNA technology for the development of live-attenuated dengue vaccines
    Lee, Hsiang-Chi
    Butler, Michael
    Wu, Suh-Chin
    ENZYME AND MICROBIAL TECHNOLOGY, 2012, 51 (02) : 67 - 72
  • [43] A Live-Attenuated Listeria Vaccine (ANZ-100) and a Live-Attenuated Listeria Vaccine Expressing Mesothelin (CRS-207) for Advanced Cancers: Phase I Studies of Safety and Immune Induction
    Le, Dung T.
    Brockstedt, Dirk G.
    Nir-Paz, Ran
    Hampl, Johannes
    Mathur, Shruti
    Nemunaitis, John
    Sterman, Daniel H.
    Hassan, Raffit
    Lutz, Eric
    Moyer, Bentley
    Giedlin, Martin
    Louis, Jana-Lynn
    Sugar, Elizabeth A.
    Pons, Alice
    Cox, Andrea L.
    Levine, Jordana
    Murphy, Aimee Luck
    Illei, Peter
    Dubensky, Thomas W., Jr.
    Eiden, Joseph E.
    Jaffee, Elizabeth M.
    Laheru, Daniel A.
    CLINICAL CANCER RESEARCH, 2012, 18 (03) : 858 - 868
  • [44] Challenges to the Design of Clinical Trials for Live-Attenuated Tetravalent Dengue Vaccines
    Russell, Philip K.
    Halstead, Scott B.
    PLOS NEGLECTED TROPICAL DISEASES, 2016, 10 (08):
  • [45] Live-attenuated tetravalent dengue vaccines: The needs and challenges of post-licensure evaluation of vaccine safety and effectiveness
    Wichmann, Ole
    Vannice, Kirsten
    Asturias, Edwin J.
    de Albuquerque Luna, Expedito Jose
    Longini, Ira
    Lopez, Anna Lena
    Smith, Peter G.
    Tissera, Hasitha
    Yoon, In-Kyu
    Hombach, Joachim
    VACCINE, 2017, 35 (42) : 5535 - 5542
  • [46] Single-shot live-attenuated chikungunya vaccine in healthy adults: a phase 1, randomised controlled trial
    Wressnigg, Nina
    Hochreiter, Romana
    Zoihsl, Oliver
    Fritzer, Andrea
    Bezay, Nicole
    Klingler, Anton
    Lingnau, Karen
    Schneider, Martina
    Lundberg, Urban
    Meinke, Andreas
    Larcher-Senn, Julian
    Corbic-Ramljak, Irena
    Eder-Lingelbach, Susanne
    Dubischar, Katrin
    Bender, Wolfgang
    LANCET INFECTIOUS DISEASES, 2020, 20 (10): : 1193 - 1203
  • [47] Transcriptomic and Metabolic Responses to a Live-Attenuated Francisella tularensis Vaccine
    Goll, Johannes B.
    Li, Shuzhao
    Edwards, James L.
    Bosinger, Steven E.
    Jensen, Travis L.
    Wang, Yating
    Hooper, William F.
    Gelber, Casey E.
    Sanders, Katherine L.
    Anderson, Evan J.
    Rouphael, Nadine
    Natrajan, Muktha S.
    Johnson, Robert A.
    Sanz, Patrick
    Hoft, Daniel
    Mulligan, Mark J.
    VACCINES, 2020, 8 (03) : 1 - 23
  • [48] To mist or not to mist: An update on the recommendations for live-attenuated influenza vaccine
    Shelton, Chasity M.
    Gray, Morgan D.
    Crill, Catherine M.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2018, 58 (04) : 457 - 459
  • [49] Controlled human infection study underpins efficacy of the tetravalent live-attenuated dengue vaccine TV005
    Wilder-Smith, Annelies
    JOURNAL OF CLINICAL INVESTIGATION, 2024, 134 (03):
  • [50] Safety and Immunogenicity of a Rederived, Live-Attenuated Dengue Virus Vaccine in Healthy Adults Living in Thailand: A Randomized Trial
    Watanaveeradej, Veerachai
    Gibbons, Robert V.
    Simasathien, Sriluck
    Nisalak, Ananda
    Jarman, Richard G.
    Kerdpanich, Angkool
    Tournay, Elodie
    De La Barrerra, Rafael
    Dessy, Francis
    Toussaint, Jean-Francois
    Eckels, Kenneth H.
    Thomas, Stephen J.
    Innis, Bruce L.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2014, 91 (01): : 119 - 128
12345